Dergiler / Balkan Medical Journal / 2016 / Cilt: 33 - Sayı: 6

Use of Systemic Rosmarinus Officinalis to Enhance the Survival of Random-Pattern Skin Flaps

Sayfa
645–651
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Results: The mean percentage of viable surface area was significantly greater (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background: Skin flaps are commonly used in softtissue reconstruction; however, necrosis can be a frequent complication.
📊
Temel Bulgular & Veri:A rectangular random-pattern flaps measuring 8×2 cm was elevated from the back of each rat.
💡
Sonuç & Katkı:Results: The mean percentage of viable surface area was significantly greater (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background: Skin flaps are commonly used in softtissue reconstruction; however, necrosis can be a frequent complication. Several systemic and local agents have been used in attempts to improve skin flap survival, but none that can prevent flap necrosis have been identified. Aims: This study aims to determine whether the use of systemic Rosmarinus officinalis (R. officinalis) extract can prevent flap necrosis and improve skin flap recovery. Study Design: Animal experimentation. Methods: Thirty-five Wistar albino rats were divided in five groups. A rectangular random-pattern flaps measuring 8×2 cm was elevated from the back of each rat. Group I was the control group. In Group II, 0.2 ml of R. officinalis oil was given orally 2h before surgery. R. officinalis oil was then applied orally twice a day for a week. In Group III, R. officinalis oil was given orally twice a day for one week before surgery. At the end of the week, 0.2 mL of R. officinalis oil was given orally 2 h before surgery. In Group IV, 0.2 mL of R. officinalis oil was injected subcutaneously 2 h before surgery. After the surgery, 0.2 mL R. officinalis oil was injected subcutaneously twice a day for one week. In Group V, 0.2 mL R. officinalis oil was injected subcutaneously twice a day for one week prior to surgery. At the end of the week, one last 0.2 mL R. officinalis oil injection was administered subcutaneously 2 h before surgery. After the surgery, 0.2 mL R. officinalis oil was injected subcutaneously twice a day for one week. Results: The mean percentage of viable surface area was significantly greater (p

🔖

Bu Makaleye Atıf Yap

DADACI, M., BİLGEN, F., İNCE, B., GÜNDEŞLİOĞLU, A. Ö., KOZACIOĞLU, S. (2022). Use of Systemic Rosmarinus Officinalis to Enhance the Survival of Random-Pattern Skin Flaps. Balkan Medical Journal, Cilt: 33 - Sayı: 6, 645–651. https://ajindex.com/articles/461394

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Smith JD, Pribaz JJ. Flaps. In: Plastic surgery indications, op- erations and outcomes. Achauer BM, Eriksson E, Wilkins EG, Vandekam VM editors. 2nd ed. St. Louis-Missouri: Mosby, 2000; 1: 261-90.
  2. Karacaoglu E, Yuksel F, Turan SO, Zienowicz RJ. Chemical delay: an alternative to surgical delay experimental study. Ann Plast Surg 2002;49:73-80. [CrossRef] Kose R, Yildirim AM, Okur MI, Tugrul I. The effects of N?-nitro -L-arginine (L-NNA) on blood pressure and sur- vival of the skin flaps in rats. Turk Plast Surg 2010;18:6- 10. Demirel M, Heper AO, Yormuk E. Comparison of pharmaco- logic delay operation by local VEGF injection with other sur- gical delay procedures on rat dorsal skin flap. Turk Plast Surg 2010;18:24-30.
  3. Ince B, Yildirim AM, Okur MI, Dadaci M, Yoruk E. Effects of Rosmarinus officinalis on the survivability of random-patterned skin flaps: an experimental study. J Plast Surg Hand Surg 2015;49:83-7. [CrossRef] Angioni A, Barra A, Cereti E, Barile D, Coïsson JD, Arlorio M, et al. Chemical composition, plant genetic differences, antimi- crobial and antifungal activity investigation of the essential oil of Rosmarinus officinalis L. J Agric Food Chem 2004;52:3530- 5. [CrossRef] Bozin B, Mimica N, Samojlik I, Jovin E. Antimicrobial and anti- oxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L, Lamiaceae) essential oils. J Agric Food Chem 2007;55:7879-85. [CrossRef] Fu Y, Zu Y, Chen L, Efferth T, Liang H, Liu Z. Investigation of antibacterial activity of rosemary essential oil against Propi- onibacterium acnes with atomic force microscopy. Planta Med 2007:1275-80. [CrossRef] Luqman S, Dwivedi GR, Darokar MP, Kalra A, Khanuja SP. Po- tential of rosemary oil to be used in drug-resistant infections. Altern Ther Health Med 2007;13:54-9. van Vuuren SF, Suliman S, Viljoen AM. The antimicrobial activ- ity of four commercial essential oils in combination with con- ventional antimicrobials. Lett Appl Microbiol 2009;48:440-6. [CrossRef] Siurin SA. Effects of essential oil on lipid peroxidation and lipid metabolism in patients with chronic bronchitis. Klin Med (Mosk) 1997;75:43-5.
  4. Bhale SD, Xu Z, Prinyawiwatkul W, King JM, Godber JS. Oregano and rosemary extracts inhibit oxidation of long-chain n-3 fatty acids in menhaden oil. J Food Sci 2007;72:504-8. [CrossRef] Huang HC, Huang CY, Lin-Shiau SY, Lin JK. Ursolic acid inhib- its IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with